Recent Posts
- HealthInvest June 2026: A Look Inside Australia's Healthcare Innovations16 Jun 2026
- HealthInvest Returns for 2026: Meet the Companies Shaping Australian Life Sciences19 May 2026
- Lifesaving Capital: How impact investing is shaping the future of biotech30 Apr 2026
- Investor Relations: the quiet advantage powering ASX microcaps28 Nov 2025
- HealthInvest Sydney: Life Sciences in the Investor Spotlight06 Oct 2025
Archives

INVESTOR RELATIONS
26 Oct 2020
Oventus presents at IRD Invest
On 14 October 2020, Oventus CEO, Dr Chris Hart, presented at IR Department’s virtual investor conference, IRD Invest , an event designed to bring investors directly to the CEOs of emerging ASX listed…
Read article
INVESTOR RELATIONS
13 Oct 2020 · Admin
Technology 2020
Presenting companies: Michael Eidel, CEO Openpay (ASX: OPY) Openpay Group Ltd (ASX: OPY) is a well-established player in the fast-growing global market for ‘Buy now pay later’ (BNPL) payment…
Read article
INVESTOR RELATIONS
06 Oct 2020
Kazia achieves major milestones
Our client, ASX-listed oncology company Kazia Therapeutics Ltd (ASX: KZA; NASDAQ: KZIA, has had a huge few months, including the achievement of significant milestones for lead drug candidate, paxalisi...
Read article